Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

213

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

213 results for “drug screening”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov32/100

Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

ClinicalTrials.gov study NCT04964310. IPD Sharing: NO. Countries: 1. Publications: 8.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies

ClinicalTrials.gov study NCT04470947. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Study of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity Screening

ClinicalTrials.gov study NCT04267081. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

ClinicalTrials.gov study NCT05361603. IPD Sharing: NO. Countries: 1. Publications: 9.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids

ClinicalTrials.gov study NCT05024734. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A

ClinicalTrials.gov study NCT02095288. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

ClinicalTrials.gov study NCT06482086. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions

ClinicalTrials.gov study NCT03184597. IPD Sharing: YES. Countries: 1. Publications: 7.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use

ClinicalTrials.gov study NCT00876941. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development

ClinicalTrials.gov study NCT00340522. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Screening, Brief Intervention, and Referral to Treatment for Drug Use

ClinicalTrials.gov study NCT01683227. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Screening for Youth Alcohol and Drug Use: A Study of Primary Care Providers

ClinicalTrials.gov study NCT02408952. IPD Sharing: Not stated. Countries: 1. Publications: 135.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer

ClinicalTrials.gov study NCT05189171. IPD Sharing: NO. Countries: 1. Publications: 32.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Tissue Collection for Drug Screening and Bioanalysis

ClinicalTrials.gov study NCT04852354. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
zenodo28/100

Human Myeloma Cell Line (HMCL) NCATS MIPE 4.0 Drug Screen Dataset

<h3>Abstract</h3> <p>Multiple myeloma, a hematopoietic malignancy of terminally differentiated B cells, is the second most common hematological malignancy after leukemia. While patients have benefited from numerous advances in treatment in recent years resulting in significant increases to average survival time following diagnosis, myeloma remains incurable and relapse is common. To help identify novel therapeutic agents with efficacy against the disease and to search for biomarkers associated with differential response to treatment, a large-scale pharmacological screen was performed with 1,912 small molecule compounds tested at 11 doses for 47 human myeloma cell lines (HMCL). Raw and processed versions of the drug screen dataset are provided, as well as supportive information including drug and cell line metadata and high-level characterization of the most salient features of each. The dataset is publicly available at Zenodo and the workflow code used for data processing and generation of supporting figures and tables can be found at https://github.com/khughitt/hmcl-drug-screen-pipeline.</p> <h3>Overview</h3> <p>The dataset shared here contains the raw and processed versions of a high throughput small molecule&nbsp;screening dataset, as as supporting tables and figures.</p> <p>The computational pipeline used to generate the dataset is available at:&nbsp;<a href="https://github.com/khughitt/hmcl-drug-screen-pipeline">https://github.com/khughitt/hmcl-drug-screen-pipeline</a></p> <h3>Data organization</h3> <p>The .zip file available on Zenodo contains the complete output from the computational pipeline&nbsp;linked to above.</p> <p>Data and figures are organized into subfolders relating to the various pipeline steps.</p> <p>Files &amp; folders:</p> <table> <tbody> <tr> <td><strong>drugs/</strong></td> <td>Drug curves, cell line x drug AC-50 matrix, and drug metadata tables.</td> </tr> <tr> <td><strong>manuscript/</strong></td> <td>Figures and tables generated by the pipeline for the manuscript, including the harmonized cell line metadata table ("table1.tsv")</td> </tr> <tr> <td><strong>mutations/</strong></td> <td> <p>Cell line mutation predictions with identifiers harmonized to match those used in the drug screen (source: <a href="https://www.keatslab.org/data-repository">Keats Lab</a>)</p> </td> </tr> <tr> <td><strong>plates/</strong></td> <td> <p>Drug screen viability measurements at different levels of processing, arranged with one column per plate ("raw.tsv", "raw_filtered.tsv", "normed.tsv", "background_adjusted.tsv"), plate-level metadata ("metadata.tsv"), the compued background plate ("background.tsv"), and plate images used for QA.</p> </td> </tr> <tr> <td><strong>raw/</strong></td> <td>Raw version of the drug screen dataset, including the data for cell lines which were filtered out in the pipeline due to quality purposes</td> </tr> <tr> <td><strong>datapackage.yml</strong></td> <td> <p>Metadata for the provided data resources including sha256 checksums, human-readible descriptions, column types, etc. (see: <a href="datapackage.org">https://datapackage.org/</a>)</p> </td> </tr> </tbody> </table> <p>&nbsp;</p>

opencc-by-4.0Oct 2024View details →
zenodo28/100

GeCKO_v2_CRISPR_drug screens in K562 cells

<p>The data contain raw DNA deep sequencing files for GeCKO-v2 genome scale transduced K562 screens with selected drugs (imatinib, dasatinib, asciminib, tivozanib, AZD1775, mepacrine). For all drug except mepacrine the drug, day 0 and day 17 control samples&#39; files are provided. For mepacrine which was screened separately, a triplicate drug, D15 control sample files are provided. The dates are indicated in the file names.&nbsp;</p>

openJun 2023View details →
zenodo28/100

Fig. 2 in Design, synthesis and screening of a drug discovery library based on an Eremophila-derived serrulatane scaffold

Fig. 2. Key COSY, HMBC and ROESY correlations of analogue 5.

opennotspecifiedOct 2021View details →
ClinicalTrials.gov28/100

Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and Treatment

ClinicalTrials.gov study NCT06249542. IPD Sharing: NO. Countries: 0. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia

ClinicalTrials.gov study NCT06463912. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Drug Screening Using Novel IMD in Renal Cell Carcinoma

ClinicalTrials.gov study NCT05700461. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record